OncoTherapy Science, Inc. (4564.T) JPX
22.00
-1(-4.35%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
22.00
-1(-4.35%)
Currency In JPY
| Market Cap | 7.31B |
| Enterprise Value | 6.53B |
| P/E Ratio | -9 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 9.64 |
| Price/Book Ratio | 3.71 |
| Enterprise/Revenue | 6.86 |
| Enterprise/EBITDA | -6.01 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.12 |
| Operating Margin | -1.04 |
| Return On Assets | -0.36 |
| Return On Equity | -0.63 |
| Revenue | 750.05M |
| Revenue/Share | 2.17 |
| Gross Profit | -12.76M |
| EBITDA | -811.92M |
| Net Income | -815.29M |
| Diluted EPS | -3.12 |
| Total Cash | 2.19B |
| Total Cash/Share | 6.06 |
| Total Debt | 9.29M |
| Total Debt/Equity | 0 |
| Current Ratio | 8.51 |
| Book Value Per Share | 5.93 |
| 52-Week Change | -15.38 |
| 52-Week High | 35 |
| 52-Week Low | 19 |
| Moving Average 50 Days | 21.1 |
| Moving Average 200 Days | 23.9 |
| Average Volume | 41.27M |
| Shares Outstanding | 343.64M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 500:1 |
| Last Split Date | September 26, 2013 |